CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Brissot E, Peczynski C, Labopin M, Lussana F, Hough R, Kuball J, Rösler W, Furst S, Barba P, Daskalakis M, Gungor T, Bierings M, Besley C, Sakellari I, Karakasis D, Kwon M, Fegueux N, Ruggeri A, Chabannon C, Giebel S, Peric Z, Nagler A, Ciceri F, Mohty M (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Pages Range: 10389-10390

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2022-158880

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Brissot, E., Peczynski, C., Labopin, M., Lussana, F., Hough, R., Kuball, J.,... Mohty, M. (2022). CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). In BLOOD (pp. 10389-10390). WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Brissot, Eolia, et al. "CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2022. 10389-10390.

BibTeX: Download